F-1: Softto, Inc. Files for $20.7 Million IPO on NASDAQ
Registration Statement (Form F-1)
Softto, Inc., a Cayman Islands holding company operating in China's personal care market, seeks to raise capital through an initial public offering on the NASDAQ Capital Market.
Summary
- Softto, Inc., a Cayman Islands-based holding company, has filed a registration statement for an initial public offering (IPO) on the NASDAQ Capital Market.
- The company plans to offer 3,000,000 ordinary shares with an expected price range of $4 to $6 per share, aiming to raise approximately $20.7 million.
- Softto operates in China through its subsidiaries, focusing on the development, sale, and distribution of hair care, skin care, personal care, and beauty products.
- The company's brands include Softto, Softto Oriental Herbs, i-softto, Dakeshu, Qingyuan, and Welltop, sold in 238 cities across China.
- Revenues for the fiscal year 2023 were approximately $15.0 million, with a net loss of $2.3 million.
- The company intends to use the IPO proceeds for business operations, strategic investments, product development, and expansion of its online store network.
- The offering is subject to regulatory filings with the CSRC and compliance with U.S. securities laws, including the Holding Foreign Companies Accountable Act.
- Revere Securities LLC is acting as the underwriter for the offering, with a 45-day over-allotment option to purchase up to an additional 15% of the shares.
Sentiment
Score: 5
Explanation: The document presents a mixed sentiment. While the company has a strong brand history and growth strategies, it also faces financial challenges and regulatory risks. The IPO aims to address these challenges, but success is not guaranteed.
Positives
- The company has a well-established brand history in China, starting in 1988.
- Softto has a comprehensive sales and marketing management system with an extensive distribution network.
- The company has a market-driven research and development team focused on product innovation.
- Softto offers attractive product pricing, appealing to price-sensitive consumers.
- The company has a comprehensive management system and an experienced management team.
Negatives
- The company incurred a net loss of $2.3 million in 2023 and $0.4 million in 2022.
- The company's revenue decreased by 23.4% from 2022 to 2023.
- The company faces intense competition in the beauty and personal care products market in China.
- The company relies on a limited number of vendors, with one supplier accounting for a significant portion of purchases.
- The company may need additional capital, and financing may not be available on acceptable terms.
Risks
- Changes in China's economic, political, or social conditions could adversely affect the business.
- The company may rely on dividends from its PRC subsidiary, which could be limited.
- PRC regulations on loans and direct investment may restrict the use of IPO proceeds.
- The Holding Foreign Companies Accountable Act could lead to delisting of the company's shares.
- There is no guarantee that an active trading market for the company's shares will develop.
Future Outlook
The company intends to enhance its competitive position and expand its market share by upgrading product supply through technological innovation, expanding its sales network, enhancing its ability to attract and retain talented professionals, and seeking strategic partnerships and acquisitions.
Management Comments
- Our product and its quality speak for itself.
- We keep up with the development and change of trends in personal care products industry in China and pursue constant improvements of our products.
- We develop and sell every type and model of our products with high standards to meet market and consumer demands, and to provide quality body skin care brand products for our customers.
Industry Context
The personal care products industry in China is experiencing rapid growth, driven by increasing disposable income, urbanization, and the expansion of online channels. The market is competitive, with both international and domestic brands vying for market share. Consumers are increasingly seeking sustainable and specialized products.
Comparison to Industry Standards
- The company's revenue of approximately $17.5 million in 2022 represents a small market share (0.02%) compared to major players like P&G, Unilever, and L'Oreal in China's personal care market.
- Domestic brands like Jahwa, Lafang, and Bawang have market shares ranging from 0.04% to 0.8%, indicating a growing trend of local companies gaining prominence.
- The company's growth strategy aligns with industry trends, focusing on online channels, product innovation, and strategic partnerships, similar to other successful brands in the market.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Executive Officer | NA | Yuhao Liang | January 14, 2025 | Appointment |
| Chairman of the Board | NA | Yuhao Liang | January 14, 2025 | Appointment |
| Chief Financial Officer | NA | Yue Chang | January 13, 2025 | Appointment |
Related Party Transactions
- The company has significant related party transactions, including purchases from Guangzhou Tianwen Jiaoyan Cosmetics Co., Ltd., controlled by the sister of Mr. Yuhao Liang.
- The company has loans to and from related parties, including Guangxi Softto Group Co., Ltd. and Guangzhou Soffto Zhimei Technology Partnership Enterprise (Limited Partnership).
Stakeholder Impact
- Shareholders face risks related to the company's financial performance, regulatory environment, and potential delisting.
- Employees may be affected by changes in compensation, benefits, and working conditions.
- Customers may experience changes in product availability, quality, and pricing.
- Suppliers may be impacted by changes in procurement policies and payment terms.
- Creditors face risks related to the company's ability to repay debts.
Next Steps
- Complete the review process by CSRC for filings related to the IPO.
- Secure listing approval on the NASDAQ Capital Market.
- Execute the planned allocation of IPO proceeds to business operations, strategic investments, product development, and online store expansion.
Key Dates
| Date | Description |
|---|---|
| 1988 | Softto brand started in China |
| December 18, 2020 | The Holding Foreign Companies Accountable Act, or the HFCA Act, was enacted |
| July 6, 2021 | The General Office of the Communist Party of China Central Committee and the General Office of the State Council jointly issued an announcement to crack down on illegal activities in the securities market |
| December 28, 2021 | Cybersecurity Review Measures was published by Cyberspace Administration of China |
| February 15, 2022 | Cybersecurity Review Measures became effective |
| July 7, 2022 | CAC promulgated the Measures for the Security Assessment of Data Cross-border Transfer |
| September 1, 2022 | Measures for the Security Assessment of Data Cross-border Transfer became effective |
| February 17, 2023 | The CSRC released the Trial Administrative Measures of Overseas Securities Offering and Listing by Domestic Enterprises (the New Overseas Listing Rules) |
| March 31, 2023 | The New Overseas Listing Rules took effect |
| February 24, 2023 | The CSRC, the Ministry of Finance, the National Administration of State Secretes Protection and the National Archives Administration released the Provisions on Strengthening the Confidentiality and Archives Administration Related to the Overseas Securities Offering and Listing by Domestic Companies |
| March 31, 2023 | The Confidentiality and Archives Administration Provisions took effect |
| January 14, 2025 | Yuhao Liang appointed as the Chief Executive Officer of the Company and Chairman of the Board |
| January 13, 2025 | Yue Chang appointed as the Chief Financial Officer of the Company |
Keywords
IPO, initial public offering, Softto, personal care products, China, NASDAQ, beauty products, Revere Securities, investment, equity
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.